DEVV — Bioscience Neutraceuticals Cashflow Statement
0.000.00%
Last trade - 00:00IndustrialsHighly SpeculativeMicro Cap
Annual cashflow statement for Bioscience Neutraceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2015 December 31st | C2016 December 31st | 2017 December 31st | 2018 December 31st | 2019 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.048 | -0.011 | -0.15 | -0.074 | -0.626 |
| Non-Cash Items | — | 0 | 0.109 | 0.004 | 0.559 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.005 | 0.005 | -0.001 | 0.022 | 0.03 |
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -0.043 | -0.006 | -0.042 | -0.047 | -0.037 |
| Other Investing Cash Flow Items | 0 | 0 | -0.048 | -0.001 | 0 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0 | 0 | -0.048 | -0.001 | 0 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0 | 0.004 | 0.091 | 0.047 | 0.037 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.043 | -0.002 | 0.001 | -0.001 | 0 |